What cash-pay care costs, and who to trust
An independent guide to paying cash for care in the US. Every price carries the date we checked it and its source, and every company we review is checked against FDA warning letters, BBB records and court filings.
Compare GLP-1 pricesFind care in your city
- 68FDA warning letters tracked
- 49companies checked
- 55metro areas covered
- Zepbound vial or KwikPenLillyDirect$299 to $449 [1]a month, by dose
- Wegovy penNovoCare Pharmacy$349 [2]a month$199 for the first two fills of 0.25 or 0.5 mg through Dec 31, 2026 [2]
- Wegovy pillNovoCare Pharmacy$149 to $299 [2]a month, by dose
- Foundayo pillLillyDirect$149 to $299 [3]a month, by dose
- OzempicNovoCare Pharmacy$349 to $499 [4]a monthApproved for type 2 diabetes, not weight loss [4]
- Medicare GLP-1 BridgePart D, if you qualify$50 [5]copay a monthRuns Jul 1, 2026 to Dec 31, 2027 [6]
Choose the care you are paying for
Prices, hidden costs and what to check before you pay, by type of care.
- Weight loss and GLP-1s
Zepbound, Wegovy, the new pills, compounded versions and online programs, compared on price and record.
- Menopause hormone therapy
Estrogen and progesterone options, online programs and what they cost.
FDA approved label changes that drop some boxed warning language [9] [10]
- Testosterone therapy
TRT clinics, online programs, enclomiphene and what the label says about blood pressure.
Class-wide label changes in February 2025 [11]
- Concierge medicine
Membership fees and what they cover. Medicare does not pay the membership fee [12].
- Direct primary care
A flat monthly fee for primary care, and how it works with an HSA.
Typically $50 to $100 a month, per the AAFP [15]
- Longevity testing
Lab memberships, full body MRI, calcium scores and biological age tests, with what the evidence says.
- Wellness injections
NAD+, B12, sermorelin and other shots: FDA status, what compounded means, and what is known.
- Executive physicals
What hospital and private programs include, and which publish a price.
How we check a company
Every company gets the same test, whether or not it could ever pay us.
- 1
Read the price where it is sold
We take each price from the company's or drugmaker's own page, write down the date, and list what it leaves out: visits, labs, shipping and dose step-ups.
- 2
Check the record
We search FDA warning letters, BBB profiles, court filings and FTC actions before we write a review.
- 3
Apply one rule
Live claims FDA cited, a BBB rating of D or F, a pattern of billing complaints or regulator action means Avoid. We never link to a company rated Avoid.
Where our reviews stand
- Clean28No FDA letter, complaint pattern or regulator action found.
- Use caution8A past FDA letter whose cited claims were fixed, and a reasonable record.
- Avoid9Fails the rule. No links, whatever the company pays.
- Not yet rated4Not enough confirmed to rate yet, so no links.
FDA warning letters, tracked
On Mar 3, 2026, FDA announced warning letters to 30 telehealth companies over how they marketed compounded GLP-1s [7]. Our tracker lists each letter with what FDA cited and links to the letter itself. The newest went to Empower Pharmacy, a large compounding pharmacy [8].
- Sep 18, 2026Empower Clinic Services, LLC dba Empower PharmacyRead the letter on fda.gov
- Aug 24, 2026Peptide Partners LLCRead the letter on fda.gov
- Aug 24, 2026Royal Peptides LLCRead the letter on fda.gov
Find care in your city
Local guides with county health data, state Medicaid rules and the state medical board for each metro.
Questions people ask
Is Wellchosen Health a medical provider?
No. Wellchosen Health is an independent consumer guide. It does not prescribe, sell or ship any drug or treatment, and nothing on the site is medical advice. For care, talk with a licensed clinician. In an emergency, call 911.
How much does Zepbound cost without insurance?
What is the cheapest brand GLP-1 without insurance?
How does Wellchosen Health make money?
Two ways: affiliate links to some telehealth companies, which are placeholders until we join those programs, and labeled Sponsored placements for local practices on city pages, from $300 a month. Companies rated Avoid or Not yet rated never get affiliate links, and payment never changes a verdict. Details are on how we make money.
How do you decide a company is rated Avoid?
A company is rated Avoid if it has an FDA warning letter whose cited claims are still live, a BBB rating of D or F, a pattern of billing or refund complaints, or regulator or pharmacy action against it. Use caution means a past FDA letter with the claims fixed and a reasonable complaint record. Clean means none of these. The full rule is in our editorial standards.
Has a doctor reviewed these pages?
Not yet. Pages are written by the Wellchosen Health editorial team from FDA labels, peer-reviewed trials and government data. Each page shows "Medical review: pending" until a named licensed clinician reviews it. Our medical review policy explains how a reviewer will be added.
Sources
17 cited
- Zepbound self-pay prices. Eli Lilly and Company (LillyDirect), Oct 17, 2026.
- Wegovy self-pay offer. Novo Nordisk (NovoCare Pharmacy), Oct 17, 2026.
- Foundayo self-pay prices. Eli Lilly and Company (LillyDirect), Oct 17, 2026.
- Ozempic self-pay prices. Novo Nordisk (NovoCare Pharmacy), Oct 17, 2026.
- Weight loss drugs coverage. Medicare.gov (CMS), Oct 17, 2026.
- Medicare GLP-1 Bridge: information for pharmacies. Centers for Medicare & Medicaid Services, Oct 17, 2026.
- FDA warns 30 telehealth companies against illegal marketing of compounded GLP-1s. U.S. Food and Drug Administration, Mar 3, 2026.
- Warning letter: Empower Clinic Services, LLC dba Empower Pharmacy. U.S. Food and Drug Administration, Sep 18, 2026.
- Fact sheet: FDA initiates removal of black box warnings from menopausal hormone replacement therapy products. U.S. Department of Health and Human Services, Nov 10, 2025.
- FDA approves labeling changes for menopausal hormone therapy products. U.S. Food and Drug Administration, Feb 12, 2026.
- FDA issues class-wide labeling changes for testosterone products. U.S. Food and Drug Administration, Feb 28, 2025.
- Concierge care. Medicare.gov (CMS), Oct 17, 2026.
- Mayy Deadrick, MD (MDVIP physician page). MDVIP, Oct 17, 2026.
- Brooke J. Nevins, MD (MDVIP physician page). MDVIP, Oct 17, 2026.
- Direct primary care. American Academy of Family Physicians, Oct 17, 2026.
- Function Health pricing. Function Health, Oct 17, 2026.
- Prenuvo pricing. Prenuvo, Oct 17, 2026.
This page is general information, not medical advice. Talk with a licensed clinician about your own care.